News | February 27, 2012

AT&T to Wirelessly Connect Boston Scientific Cardiac Devices

Subject to its devices receiving necessary U.S. Food and Drug Administration (FDA) approvals, Boston Scientific Corp. will have the capability to transmit implantable cardiac device data to physicians and other healthcare providers in North America across the AT&T wireless network in the future, AT&T announced.

Using its clinical expertise in remote patient monitoring, Boston Scientific plans to embed AT&T wireless technology in its Latitude Patient Management system, which will be utilized in the company's future lines of pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators and pacemakers (CRT-Ds and CRT-Ps).

Boston Scientific's current remote monitoring system allows physicians the ability to conduct remote follow-up of implantable cardiac device patients to monitor specific device information and heart health status. The system can also detect clinical events between scheduled visits and send relevant data directly to a highly secure website that can be accessed by physicians. Future wireless connectivity under the new agreement will allow the transmission of data to physicians from most locations without the need for landline-based technology.

"There is no question that the convergence of healthcare and mobile technology is happening today and offers limitless opportunities in the future. We are very focused in helping drive this innovation. Together with Boston Scientific, we will enable more convenient care for patients and more opportunities for physicians," said Glenn Lurie, president of emerging devices for AT&T Mobility.

"Physicians are asking for flexible connectivity solutions for remote monitoring systems that can improve efficiency," said Joe Fitzgerald, senior vice president and president of the Cardiac Rhythm Management Unit for Boston Scientific. "Boston Scientific is pleased to collaborate with AT&T and benefit from its depth and breadth of cellular technology expertise to help physicians and their patients."

For more information: www.att.com.

Related Content

Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement| October 19, 2017
October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professio
The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure| October 18, 2017
October 18, 2017 — The U.S.
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Spectranetics Initiates Class I Recall for Bridge Occlusion Balloon Catheter
News | EP Lab| September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Overlay Init